Most cases of chronic kidney disease relate to underlying conditions, so the best treatment for you depends on your health ...

Roche and KlinRisk have secured CE mark approval for their AI-driven risk stratification tool, designed for evaluating the ...

Chronic Kidney Disease (CKD) is often measured by numbers—declining filtration rates, rising creatinine, and fluctuating ...

The algorithm will be added to Roche's navify library of clinical decision-making algorithms and other digital health ...

Chronic Kidney Disease (CKD) is usually described in terms of numbers: Decreasing filtration rates, increasing creatinine, ...

Objectives: This study aimed to evaluate the effectiveness of value-based care (VBC) interventions in slowing the progression of chronic kidney disease (CKD), as measured by changes in estimated ...

A population-based study of 618,739 adults using electronic health record data, published in the Clinical Journal of the ...

Roche receives CE Mark for AI-based Kidney Klinrisk Algorithm and launches new comprehensive CKD algorithm panel: Basel Tuesday, October 7, 2025, 11:00 Hrs [IST] Roche, in collabo ...

A new drug lowered blood pressure and improved kidney health markers in high-risk patients. Phase 3 trials will test its long-term effects. Preliminary research suggests that adding the new medication ...

Chronic kidney disease (CKD) is a frequent contemporary concern and a major cause of death among patients in the United States with systemic lupus erythematosus (SLE).

Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function.

Clinicians and their patients with chronic kidney disease (CKD) need to be aware of zinc intake and anemia status.